These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7107976)

  • 41. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preference studies of triazolam with standard hypnotics in out-patients with insomnia.
    Fabre LF; McLendon DM; Harris RT
    J Int Med Res; 1976; 4(4):247-54. PubMed ID: 16801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of estazolam on sleep, performance, and memory: a long-term sleep laboratory study of elderly insomniacs.
    Vogel GW; Morris D
    J Clin Pharmacol; 1992 Jul; 32(7):647-51. PubMed ID: 1640005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypnotic efficacy of lorazepam and flurazepam.
    Wang RI; Stockdale SL; Hieb E
    Clin Pharmacol Ther; 1976 Feb; 19(2):191-5. PubMed ID: 4255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indole-3-pyruvic acid as a possible hypnotic agent in insomniac subjects.
    Silvestri R; Mento G; Raffaele M; De Luca G; Buttini G; Casella C; Tisano A; De Domenico P; Di Rosa AE; Di Perri R
    J Int Med Res; 1991; 19(5):403-9. PubMed ID: 1748233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma concentrations of flurazepam and midazolam in chronic insomniacs during 14-day use and their relationship to therapeutic effects and next-day performance and mood.
    Ellinwood E; Linnoila M; Marsh G
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):68S-75S. PubMed ID: 2229465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temazepam's efficacy in patients with sleep onset insomnia.
    Roehrs T; Lamphere J; Paxton C; Wittig R; Zorick F; Roth T
    Br J Clin Pharmacol; 1984 Jun; 17(6):691-6. PubMed ID: 6146327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative efficacy of estazolam, flurazepam, and placebo in outpatients with insomnia.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1986 Jul; 47(7):362-5. PubMed ID: 2873132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nighttime and daytime efficacy of flurazepam and oxazepam in chronic insomnia.
    Bliwise D; Seidel W; Greenblatt DJ; Dement W
    Am J Psychiatry; 1984 Feb; 141(2):191-5. PubMed ID: 6691478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia.
    Deacon S; Staner L; Staner C; Legters A; Loft H; Lundahl J
    Sleep; 2007 Mar; 30(3):281-7. PubMed ID: 17425224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of flurazepam on sleep spindles and K-complexes.
    Johnson LC; Hanson K; Bickford RG
    Electroencephalogr Clin Neurophysiol; 1976 Jan; 40(1):67-77. PubMed ID: 55349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam.
    Judd LL; Ellinwood E; McAdams LA
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):56S-67S. PubMed ID: 2229464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs.
    Sateia MJ; Hauri P; Kripke D; Roehrs T
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):28S-31S. PubMed ID: 2229460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind evaluation of temazepam, flurazepam, and placebo in geriatric insomniacs.
    Fillingim JM
    Clin Ther; 1982; 4(5):369-80. PubMed ID: 6121625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of flurazepam on disturbed sleep in patients with AIDS].
    Henkes H; Kubicki S; Hansen ML; Terstegge K; Scholz G; Ruhnke M
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Dec; 20(4):295-301. PubMed ID: 2514089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Issues in the diagnosis and treatment of insomnia.
    Dement W; Seidel W; Carskadon M
    Psychopharmacology Suppl; 1984; 1():11-43. PubMed ID: 6382252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A clinical and psychometric evaluation of flurazepam.
    Salkind MR; Silverstone T
    Br J Clin Pharmacol; 1975 Jun; 2(3):223-6. PubMed ID: 10943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of acute administration of brotizolam in subjects with disturbed sleep.
    Roehrs T; Zorick F; Koshorek GL; Wittig R; Roth T
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):371S-376S. PubMed ID: 6661383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.